Cerus Corp
Fechado
SetorSaúde
2.48 1.22
Visão Geral
Variação de preço das ações
24h
Mín
2.46
Máximo
2.5
Rendimento | -1.3M -3M |
|---|---|
Vendas | -2.5M 57M |
EPS | -0.01 |
Margem de lucro | -5.191 |
Funcionários | 261 |
EBITDA | -1.5M -712K |
Próximos Ganhos | 5 de nov. de 2026 |
|---|
Capitalização de Mercado | -93M 522M |
|---|---|
Abertura anterior | 1.26 |
Fecho anterior | 2.48 |
Sentimento de Notícias
By Acuity
39%
61%
93 / 339 Ranking em Healthcare
Cerus Corp Gráfico
O desempenho passado não é um indicador confiável de resultados futuros.
Notícias Relacionadas
Comparação entre Pares
Variação de preço
Cerus Corp Previsão
Sentimento
By Acuity
93 / 339 Ranking em Saúde
Sentimento de Notícias
Evidência de Tendência de Alta
Volatilidade
Abaixo da média
Volume de Notícias (RCV)
Acima da média
Informação Financeira
Custos administrativos e de venda
Custos Operacionais
Lucro antes de imposto
Vendas
Custo das vendas
Lucro bruto sobre vendas
Despesa com juros da dívida
EBITDA
Resultado Operacional
$
Sobre Cerus Corp
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.